CEO's use of Eli Lilly's (LLY) weight loss drug Mounjaro over Novo Nordisk's (NVO) rival product, Ozempic. Read more here.

A visual look at Wall Street's Santa Claus rallies since 2000, even as such a rally comes under pressure on Thursday. Read ...

AliExpress International and South Korea-based E-Mart's e-commerce platform Gmarket are forming a 50-50 joint venture in ...

Green Brick's Q3 2024 revenues were $523 million, which is a 25.7% increase YoY. It offers the possibility of buying a solid ...

TFLO is a top choice for reliable income investing, offering stability and above-average yields in uncertain market ...

Leggett & Platt's vertical integration and restructuring plans are expected to enhance operating margins and free cash flow ...

Dropbox has had a nice run, but the honeymoon period of people defaulting into their premium tier appears to be over. Read ...

Siemens Energy (SMEGF) is positioned to benefit from AI and electrification trends, with strong revenue growth in gas and ...

Melco Resorts' Q324 shows improvement. Substantial debt and upcoming maturities pose significant financial risks. Read an ...

Read here for an analysis of Intuitive Surgical (ISRG) stock's growth and valuation, highlighting potential risks and future ...

AT&T's stock dip presents a buying opportunity with strong Fiber growth and cash flow outlook, making it appealing for ...

Lone Pine Capital's 13F portfolio value increased from $12.33B to $13.41B, with holdings rising from 24 to 29, led by Meta, ...